

Cover Story
By Matthew Bin Han Ong
The House Committee on Energy and Commerce is spearheading legislation aimed streamlining development of drugs and medical devices.
By Matthew Bin Han Ong
In Brief


Trending Stories
- Christine Lovly to lead City of Hope’s new national thoracic oncology program
- FDA to remove black box warnings on hormone therapy for menopause
Trump-era “gold standard science” is not to be confused with gold standard of scientific evidence - Montefiore Einstein Director Edward Chu dies of glioblastoma at 66
- Rick Pazdur’s CDER appointment comes at exactly the right moment for FDA
- Smoldering multiple myeloma: Rethinking the waiting game
- Richard Pazdur, a respected insider with a plan to reengineer FDA, steps in as CDER director










